Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension

Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)

(2019) Moritz Mirna et al.   Heart Lung and Circulation

N-terminal pro–B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

(2018) Steffen D. Kriechbaum et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction

(2018) Rudolf A. de Boer et al.   JAMA Cardiology

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience

(2017) Karen M. Olsson et al.   EUROPEAN RESPIRATORY JOURNAL

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction

(2017) Omar F. AbouEzzeddine et al.   Journal of the American Heart Association

Multiple Beneficial Effects of Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension

(2016) Shunsuke Tatebe et al.   CIRCULATION JOURNAL

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

(2016) Kai C. Wollert et al.   CLINICAL CHEMISTRY

Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH)

(2016) David W.M. Muller et al.   EuroIntervention

Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension

(2016) Stefan Guth et al.   Expert Review of Respiratory Medicine

Current Concepts in the Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension

(2016) Daniel T. Matthews et al.   Pulmonary Circulation

The Biology of ST2: The International ST2 Consensus Panel

(2015) Domingo A. Pascual-Figal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases

(2015) Thomas Mueller et al.   CLINICA CHIMICA ACTA

Markers of fibrosis, inflammation, and remodeling pathways in heart failure

(2015) Claudio Passino et al.   CLINICA CHIMICA ACTA

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension

(2015) Takeshi Ogo   CURRENT OPINION IN PULMONARY MEDICINE

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

State of the Art: Newer biomarkers in heart failure

(2015) Rudolf A. de Boer et al.   EUROPEAN JOURNAL OF HEART FAILURE

Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension

(2015) Brett E. Fenster et al.   HEART AND VESSELS

Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis

(2015) Mina Hur et al.   Annals of Laboratory Medicine

Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers

(2014) Jesús Sánchez-Más et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination

(2013) Ayako Chida et al.   CIRCULATION JOURNAL

Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension

(2013) Guido Carlomagno et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Soluble ST2 Serum Concentration and Renal Function in Heart Failure

(2013) Antoni Bayes-Genis et al.   JOURNAL OF CARDIAC FAILURE

Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

(2012) Masaharu Kataoka et al.   Circulation-Cardiovascular Interventions

Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension

(2012) Hiroki Mizoguchi et al.   Circulation-Cardiovascular Interventions

Temporal changes of soluble ST2 after cardiovascular interventions

(2012) Sanne Willems et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2

(2012) Thomas Mueller et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study

(2011) Lori B. Daniels et al.   EUROPEAN JOURNAL OF HEART FAILURE

Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension

(2011) C. J. Rhodes et al.   HEART

A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism

(2011) F.A. Klok et al.   THROMBOSIS RESEARCH

Association of ST2 levels with cardiac structure and function and mortality in outpatients

(2010) Lori B. Daniels et al.   AMERICAN HEART JOURNAL

Serum Soluble ST2

(2010) Robin A.P. Weir et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assay

(2009) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension

(2008) Nils Nickel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure

(2008) T. Mueller et al.   CLINICAL CHEMISTRY